Delivery Order SPE2DB20D2104-SPE2DB24FR03U
Award Date 11/3/23
Potential Completion Date 11/6/23
Potential Value $7.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 MG TABLET 60S. The contract is a Firm Fixed Price arrangement with a ceiling value of $33,626.47 and an ultimate completion date of September 20, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,811.26, is for the supply of XIFAXAN 550 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of January 3, 2024 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price agreement with a ceiling value of $2,506.36 and a period of performance through November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $79,753.90, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of May 21, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The award has a ceiling value of $14,640.12 and a completion date of May 15, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant...
- This is a $6,318.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a medication, with a period of performance through June 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, with a ceiling value of $2,550.96 and a period of performance through May 2, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,431.40 firm fixed price contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The delivery order has an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $20,425.73, is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a firm-fixed price delivery order with a performance period ending on May 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,308.99, is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price Delivery Order with a performance period ending on January 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...